14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
EHC vs ACHC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Acadia Healthcare Company, Inc. (ACHC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ACHC carries 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin).
Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. ACHC 33.1/100 SELL), ACHC captures the overall institutional head-to-head verdict (3–7 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.8% vs. 18.4% operating margin) and revenue trajectory (+5.1% vs. +8.9% YoY).
Competes within the Medical Care Facilities value chain with $3.2B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment31.2% of Rev ($1.06B)
90D Engineering Disclosures0 Published
Investor FAQ EHC vs ACHC Key Questions & Quantitative Answers
As of Nov 20, 2026, Acadia Healthcare Company, Inc. (ACHC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ACHC carries 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin). Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. ACHC 33.1/100 SELL), ACHC captures the overall institutional head-to-head verdict (3–7 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.8% vs. 18.4% operating margin) and revenue trajectory (+5.1% vs. +8.9% YoY).
EHC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with ACHC at +5.1% YoY revenue growth and -5.1% YoY earnings growth on $3.41B TTM revenue (41.0% gross margin, 9.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while ACHC shifted +74.2%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($1.06B) (0 disclosures) for ACHC.
ACHC screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas ACHC trades at 17.0x Forward P/E, 16.9x Trailing P/E, 1.37x PEG, and 1.6x EV/Revenue (-0.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus ACHC (-40.5% ROE) capital efficiency.
In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, ACHC carries 49.8% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.39x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.68β · 61% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.